Trace Neuroscience

Trace Neuroscience, Inc. is a biotechnology company developing genetic medicines for neurodegenerative diseases. Its lead investigational medicine, TRCN-1023, is designed to restore the function of the UNC13A protein, which is disrupted in most people living with amyotrophic lateral sclerosis (ALS). The company sponsors the FUNCtion ALS Phase 1/2 trial (NCT07674667) evaluating TRCN-1023 delivered by intrathecal injection. Trace Neuroscience is backed by GV and does not currently publish a public developer portal or APIs.

Trace Neuroscience is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Neuroscience, and ALS.

🌐 Visit website 📡 Source on GitHub

9.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

Company Life Sciences Biotechnology Neuroscience ALS Therapeutics Clinical Trials

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 9.8/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/trace-neuroscience: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: trace-neuroscience
name: Trace Neuroscience
description: Trace Neuroscience, Inc. is a biotechnology company developing genetic medicines for neurodegenerative diseases.
  Its lead investigational medicine, TRCN-1023, is designed to restore the function of the UNC13A protein, which is disrupted
  in most people living with amyotrophic lateral sclerosis (ALS). The company sponsors the FUNCtion ALS Phase 1/2 trial (NCT07674667)
  evaluating TRCN-1023 delivered by intrathecal injection. Trace Neuroscience is backed by GV and does not currently publish
  a public developer portal or APIs.
url: https://raw.githubusercontent.com/api-evangelist/trace-neuroscience/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.traceneuro.com/wp-content/uploads/2024/09/piano.jpg
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Life Sciences
- Biotechnology
- Neuroscience
- ALS
- Therapeutics
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.traceneuro.com
- type: PrivacyPolicy
  url: https://www.traceneuro.com/privacy-policy/
- type: TermsOfService
  url: https://www.traceneuro.com/terms-of-service/
- type: DomainSecurity
  url: security/trace-neuroscience-domain-security.yml
- type: LLMsTxt
  url: llms/trace-neuroscience-llms.txt
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 2
  pass: local-v1